Skip to main content

Table 4 Results of sensitivity analyses

From: Cost-effectiveness of the SLIMMER diabetes prevention intervention in Dutch primary health care: economic evaluation from a randomised controlled trial

 

Sample size per group

Incremental effect

Incremental costs

ICER

Dominance

Probability cost-effective (WTPa €20,000/QALY)

Probability cost-effective (WTPa €80,000/QALY)

 

Intervention

Control

QALY

€/QALY

%

%

%

Societal perspective

145

143

0.02

547

28.094

30

43

70

Health care perspective

145

143

0.02

265

13.605

26

56

81

Complete cases

123

119

0.02

600

24.586

32

48

75

Reduced intervention costs

145

143

0.02

414

21.266

34

47

73

  1. aWTP Willingness to pay